These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36504336)

  • 1. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Price AM; Flannery B; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Mutnal M; Geffel KM; Nowalk MP; Tartof SY; Florea A; McLean C; Kim SS; Patel MM; Chung JR
    Clin Infect Dis; 2023 Apr; 76(8):1358-1363. PubMed ID: 36504336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
    Tenforde MW; Weber ZA; DeSilva MB; Stenehjem E; Yang DH; Fireman B; Gaglani M; Kojima N; Irving SA; Rao S; Grannis SJ; Naleway AL; Kirshner L; Kharbanda AB; Dascomb K; Lewis N; Dalton AF; Ball SW; Natarajan K; Ong TC; Hartmann E; Embi PJ; McEvoy CE; Grisel N; Zerbo O; Dunne MM; Arndorfer J; Goddard K; Dickerson M; Patel P; Timbol J; Griggs EP; Hansen J; Thompson MG; Flannery B; Klein NP
    J Infect Dis; 2023 Jul; 228(2):185-195. PubMed ID: 36683410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022.
    Tenforde MW; Patel MM; Lewis NM; Adams K; Gaglani M; Steingrub JS; Shapiro NI; Duggal A; Prekker ME; Peltan ID; Hager DN; Gong MN; Exline MC; Ginde AA; Mohr NM; Mallow C; Martin ET; Talbot HK; Gibbs KW; Kwon JH; Chappell JD; Halasa N; Lauring AS; Lindsell CJ; Swan SA; Hart KW; Womack KN; Baughman A; Grijalva CG; Self WH;
    Clin Infect Dis; 2023 Mar; 76(6):1030-1037. PubMed ID: 36327388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
    Lewis NM; Zhu Y; Peltan ID; Gaglani M; McNeal T; Ghamande S; Steingrub JS; Shapiro NI; Duggal A; Bender WS; Taghizadeh L; Brown SM; Hager DN; Gong MN; Mohamed A; Exline MC; Khan A; Wilson JG; Qadir N; Chang SY; Ginde AA; Mohr NM; Mallow C; Lauring AS; Johnson NJ; Gibbs KW; Kwon JH; Columbus C; Gottlieb RL; Raver C; Vaughn IA; Ramesh M; Johnson C; Lamerato L; Safdar B; Casey JD; Rice TW; Halasa N; Chappell JD; Grijalva CG; Talbot HK; Baughman A; Womack KN; Swan SA; Harker E; Price A; DeCuir J; Surie D; Ellington S; Self WH;
    Clin Infect Dis; 2024 Apr; 78(4):1056-1064. PubMed ID: 38051664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.
    Flannery B; Clippard J; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Petrie JG; McLean HQ; Belongia EA; Gaglani M; Berman L; Foust A; Sessions W; Thaker SN; Spencer S; Fry AM;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):10-5. PubMed ID: 25590680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
    Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
    J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
    Chung JR; Kim SS; Kondor RJ; Smith C; Budd AP; Tartof SY; Florea A; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Reis M; Geffel KM; Nowalk MP; DaSilva J; Keong LM; Stark TJ; Barnes JR; Wentworth DE; Brammer L; Burns E; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):365-370. PubMed ID: 35271561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
    Skowronski DM; Leir S; Sabaiduc S; Chambers C; Zou M; Rose C; Olsha R; Dickinson JA; Winter AL; Jassem A; Gubbay JB; Drews SJ; Charest H; Chan T; Hickman R; Bastien N; Li Y; Krajden M; De Serres G
    J Infect Dis; 2022 Apr; 225(8):1387-1398. PubMed ID: 32215564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season - Chile, 2022.
    Olivares Barraza MF; Fasce RA; Nogareda F; Marcenac P; Vergara Mallegas N; Bustos Alister P; Loayza S; Chard AN; Arriola CS; Couto P; García Calavaro C; Rodriguez A; Wentworth DE; Cuadrado C; Azziz-Baumgartner E
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1353-1358. PubMed ID: 36301733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020.
    Tenforde MW; Kondor RJG; Chung JR; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Rao A; Kim SS; Stark TJ; Barnes JR; Wentworth DE; Patel MM; Flannery B
    Clin Infect Dis; 2021 Dec; 73(11):e4244-e4250. PubMed ID: 33367650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023.
    Chung JR; Shirk P; Gaglani M; Mutnal MB; Nowalk MP; Moehling Geffel K; House SL; Curley T; Wernli KJ; Kiniry EL; Martin ET; Vaughn IA; Murugan V; Lim ES; Saade E; Faryar K; Williams OL; Walter EB; Price AM; Barnes JR; DaSilva J; Kondor R; Ellington S; Flannery B
    Influenza Other Respir Viruses; 2024 Jun; 18(6):e13342. PubMed ID: 38923314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Krajden M; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Kwindt TL; Bastien N; Li Y
    Clin Infect Dis; 2016 Jul; 63(1):21-32. PubMed ID: 27025838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
    Skowronski DM; Chuang ES; Sabaiduc S; Kaweski SE; Kim S; Dickinson JA; Olsha R; Gubbay JB; Zelyas N; Charest H; Bastien N; Jassem AN; De Serres G
    Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study.
    Jackson ML; Ferdinands J; Nowalk MP; Zimmerman RK; Kieke B; Gaglani M; Murthy K; Petrie JG; Martin ET; Chung JR; Flannery B; Jackson LA
    BMC Public Health; 2021 Mar; 21(1):516. PubMed ID: 33726743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
    Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Feb; 62(7):119-23. PubMed ID: 23425960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.
    Dawood FS; Chung JR; Kim SS; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Dunnigan K; Foust A; Sessions W; DaSilva J; Le S; Stark T; Kondor RJ; Barnes JR; Wentworth DE; Brammer L; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(7):177-182. PubMed ID: 32078591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.